Unique ID issued by UMIN | UMIN000053959 |
---|---|
Receipt number | R000061587 |
Scientific Title | Selective Reduction Trial |
Date of disclosure of the study information | 2024/04/05 |
Last modified on | 2024/03/29 12:49:30 |
Early Safety Trial of Reduction Surgery in Multiple Pregnancies
SGT
Selective Reduction Trial
SGT
Japan |
Multiple prengancy
Obstetrics and Gynecology |
Others
NO
To establish the safety of reduction surgery techniques in Japan for reducing risks to both maternal and fetal health and improving perinatal outcomes in cases of multiple pregnancies. This involves examining complications, outcomes, as well as patient backgrounds including psychological aspects.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
Successful rate of selective reduction surgery on the day after the operation
1. Number of surviving fetuses one week after the surgery.
2. Psychological evaluation of subjects one week after the surgery.
3. Number of adverse events occurring within one week post-surgery.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
Central registration
1
Treatment
Maneuver |
Reduction surgery is performed by puncturing the uterus with a needle guided by transabdominal ultrasound between the 11th and 13th weeks of pregnancy and injecting potassium chloride into the fetal heart cavity.
18 | years-old | <= |
50 | years-old | > |
Female
1. Pregnant women who have visited our department before 14 weeks of gestation.
2. Individuals who, along with their partners, are capable of providing written consent for participation in the clinical study.
3. Participants aged 18 or older but younger than 50, with partners aged 18 or older.
4. Individuals with complications expected to significantly harm maternal health if the pregnancy continues, such as high-order multiple pregnancies or twin pregnancies.
5. Individuals without genital bleeding.
6. Individuals without ruptured membranes.
7. Individuals with a cervical length of 20 mm or more.
1. Individuals who test positive for HIV antibodies, HCV antibodies, or HBs antigen.
2. Individuals with psychiatric illness or symptoms that make participation in and continuation of the trial difficult.
3. Individuals with poor overall health status, classified under the American Society of Anesthesiologists Preoperative Physical Status Classification as ASA-PS Class 3, 4, 5, or 6.
10
1st name | Masayuki |
Middle name | |
Last name | Endo |
Osaka University Hospital
Department of Obstetrics and Gynecology
565-0871
Yamadaoka 2-15, Suita, Osaka
0668793355
mendoh@sahs.med.osaka-u.ac.jp
1st name | Kazuya |
Middle name | |
Last name | Mimura |
Osaka University Hospital
Department of Obstetrics and Gynecology
565-0871
Yamadaoka 2-15, Suita, Osaka
0668793355
mimura@gyne.med.osaka-u.ac.jp
The University of Osaka
The University of Osaka
Self funding
Ethical Review Board Osaka University Hospital
Yamadaoka 2-2, Suita, Osaka
06-6210-8296
rinri@hp-crc.med.osaka-u.ac.jp
NO
2024 | Year | 04 | Month | 05 | Day |
Unpublished
Preinitiation
2024 | Year | 03 | Month | 23 | Day |
2024 | Year | 04 | Month | 05 | Day |
2026 | Year | 03 | Month | 31 | Day |
2024 | Year | 03 | Month | 25 | Day |
2024 | Year | 03 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061587
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |